Try our Advanced Search for more refined results
Health
-
March 18, 2026
ADA Challenge to Oregon Psilocybin Law Can Proceed
An Oregon federal judge Tuesday rejected the state's health regulator's bid for a favorable judgment in a suit brought under federal antidiscrimination law, seeking to broaden access for homebound patients to the state's regulated psilocybin program.
-
March 18, 2026
Health Litigator Rejoins Holland & Knight From In-House Role
A former Holland & Knight LLP attorney has returned to the firm in Jacksonville, Florida, after a 10-year stint in-house at Florida Blue, a subsidiary of GuideWell Mutual Holding Corp.
-
March 17, 2026
9th Circ. Backs Rare FCA Theory In Huge Drug Prices Program
In a novel and potentially far-reaching decision, the Ninth Circuit on Tuesday revived a major hospital chain's False Claims Act suit accusing large pharmaceutical companies of massive overcharges in a prominent drug discount program where pricing disputes are common.
-
March 17, 2026
Dr. Oz Claims Florida Also Has Healthcare Fraud Problem
Dr. Mehmet Oz, the administrator for the Centers for Medicare & Medicaid Services, announced Tuesday that he is taking his efforts to combat healthcare-related fraud to Florida, where he says millions of dollars have been wasted on schemes involving durable medical equipment.
-
March 17, 2026
Geico Keeps RICO, Fraud Claims In NY No-Fault Billing Suit
Two New York companies must face the majority of claims in Geico's suit alleging they exploited the state's no-fault insurance laws by fraudulently billing Geico more than $2.7 million for unnecessary durable medical equipment, a federal judge ruled Tuesday.
-
March 17, 2026
Union Health Fund Wins $3.5M Debt Litigation Against Suit Co.
A Rochester, New York, suit manufacturer owes a union healthcare fund about $3.5 million, a New York federal judge ruled Tuesday, saying the fund presented evidence that the manufacturer skipped out on over two years of payments.
-
March 17, 2026
House Panel Advances Bill Aimed At Curbing ERISA Litigation
A GOP-led panel in the U.S. House of Representatives on Tuesday advanced legislation that would raise the pleading standards for proposed class action federal benefits lawsuits and delay the start of discovery in those disputes, with Democrats on the committee voting to oppose the legislation.
-
March 17, 2026
Ex-Database Administrator Settles OT Claim
A former database administrator who accused Express Scripts and two other companies of misclassifying him as an independent contractor reached a $30,000 deal with the entities to settle his federal law claim, the parties told a New York federal court.
-
March 17, 2026
Bipartisan Bill To Waive $100K H-1B Fee Gets AMA Backing
Medical organizations and a bipartisan group of lawmakers are backing federal legislation introduced Tuesday that would exempt physicians and other healthcare workers from the Trump administration's $100,000 fee on H-1B visas.
-
March 17, 2026
SEIU Pension Fund Wins $842K Suit Against NJ Nursing Home
A Service Employees International Union pension fund has won its lawsuit accusing a New Jersey nursing home of skipping out on nearly $350,000 in contributions over 13 years, with a D.C. federal judge awarding the fund the missed contributions plus damages after finding it accurately calculated the nursing home's debt.
-
March 17, 2026
9th Circ. Says Idaho Doc Must Face Wash. Fatal Overdose Suit
A Ninth Circuit panel has reversed the dismissal of a suit alleging an Idaho-based doctor overprescribed drugs to a Washington woman, leading to her death, finding that the doctor and her clinic had enough contacts with Washington for a federal district court in that state to have jurisdiction.
-
March 17, 2026
Medical Goods Co. Can't Appeal Insurance Reimbursement
A medical equipment supplier is not a "health care provider" under the Pennsylvania Workers' Compensation Act and thus cannot challenge an insurer's payment for an injured worker's medical supplies, the Pennsylvania Commonwealth Court ruled.
-
March 17, 2026
Alcon Drops $430M Lensar Deal Under Pressure From FTC
Swiss eye care company Alcon Inc. has abandoned its planned purchase of a Florida-based maker of laser treatments for cataracts, Lensar Inc., after the Federal Trade Commission threatened to block the $430 million deal.
-
March 17, 2026
Drug Developer GNQ To Go Public Via $500M SPAC Deal
Techbio company GNQ Insilico has announced plans to go public by merging with special-purpose acquisition company IB Acquisition Corp. in a deal that values it at $500 million and was built by four law firms.
-
March 17, 2026
Apple Can't Shake Most PFAS Claims In Smartwatch Suit
A California federal judge won't let Apple Inc. escape a proposed class action alleging that the wristbands of its Apple Watch products contain dangerous forever chemicals, saying the complaint is sufficient to allege that the company knew of the risks but didn't warn consumers.
-
March 17, 2026
McGuireWoods Adds Former CDC Scientist From McDermott
McGuireWoods LLP said Tuesday that it has hired a former Centers for Disease Control and Prevention scientist from McDermott Will & Schulte LLP, touting his background as a microbiologist and his history advising healthcare clients.
-
March 17, 2026
Fenwick Healthcare Regulatory Atty Rejoins Latham In LA
Latham & Watkins LLP is boosting its healthcare team, announcing Monday it is welcoming back a Fenwick & West LLP healthcare regulatory expert as a partner in its Los Angeles office.
-
March 16, 2026
PBGC Keen On Dishing Out Opinion Letters, Director Says
The Pension Benefit Guaranty Corp. has revamped its website to encourage attorneys to seek opinion letters about how the Employee Retirement Income Security Act applies to specific scenarios. PBGC Director Janet Dhillon spoke to Law360 about that effort, the PBGC's latest financial report to Congress and her goals for the agency.
-
March 16, 2026
1st Circ. Affirms Block Of Trump's 'Unprecedented' Aid Freeze
The First Circuit on Monday mostly upheld a lower court's order blocking the Trump administration from enacting a "sweeping and unprecedented categorical 'freeze' of federal financial assistance," ruling that the states involved in the suit will likely successfully show that the federal government acted arbitrarily and capriciously.
-
March 16, 2026
Md. Appeals Court Upholds Ax Of MedStar Data Sharing Suit
A Maryland state appeals court refused to revive a proposed class action accusing MedStar Health Inc. of illegally sharing patients' personal information with Facebook and Google, finding that the type of data that was allegedly divulged isn't protected by the state's wiretap statute.
-
March 16, 2026
Trump Taps Vance For Fraud Task Force, Bashing Blue States
President Donald Trump on Monday signed an executive order creating a task force chaired by Vice President JD Vance that aims to curb "fraud, waste and abuse" in federal housing, food and other benefit programs, with the president alleging "staggering fraud and waste" in Minnesota and other Democratic-led states.
-
March 16, 2026
Trump Admin Wants Student Loan Forgiveness Suits Tossed
The Trump administration on Monday asked a Massachusetts federal judge to toss a pair of lawsuits challenging a change to eligibility requirements for student loan forgiveness, calling the potential repercussions from the new rule "speculative."
-
March 16, 2026
Defamation Suit Against WWE Accuser's Lawyer Advances
A Connecticut federal judge on Friday refused to toss a doctor's defamation suit against the Holland Law Firm and one of its attorneys, saying it is premature to determine whether the plaintiff, whose patient accuses the former CEO of World Wrestling Entertainment Inc. of sex trafficking, is a public figure who has to prove actual malice.
-
March 16, 2026
Judge Tosses Kaiser Whistleblowers' Claims After $556M Deal
A California federal court on Monday officially dismissed False Claims Act lawsuits from the federal government and three people alleging that Kaiser Permanente affiliates engaged in Medicare fraud, on the heels of Kaiser's $556 million settlement reached in January.
-
March 16, 2026
Pa. Appeals Court Reinstates Kratom And Caffeine DUI Charge
A man charged with driving under the influence and other offenses after using caffeine and the herbal stimulant kratom cannot argue his case should be dismissed since he wasn't using controlled substances, the Pennsylvania Superior Court said Monday, reversing a lower court.
Expert Analysis
-
Series
The Biz Court Digest: How It Works In Massachusetts
Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.
-
How Healthcare Practices Can Prepare For ICE Visits
Healthcare providers that may face encounters with immigration enforcement should familiarize themselves with compliance obligations beyond ensuring employment authorization, and mitigate risk by establishing clear policies and specific procedures that safeguard patient rights and manage staff interactions with agents, say attorneys at Roetzel & Andress.
-
Adapting To Calif.'s Enhanced Regulation Of PE In Healthcare
New California legislation enhances oversight on the role of private equity groups and hedge funds in healthcare transactions, featuring both a highly targeted nature and vague language that will require organizations to carefully evaluate existing practices, says Andrew Demetriou at Husch Blackwell.
-
Why Appellees Should Write Their Answering Brief First
Though counterintuitive, appellees should consider writing their answering briefs before they’ve ever seen their opponent’s opening brief, as this practice confers numerous benefits related to argument structure, time pressures and workflow, says Joshua Sohn at the U.S. Department of Justice.
-
Navigating DEA Quotas: Key To Psychedelics Industry Growth
As new compounds like DOI enter the Schedule I landscape, manufacturers who anticipate U.S. Drug Enforcement Administration quota regulations, and build quota management into their broader strategy, will be best equipped to meet the growing demand, say Kimberly Chew at Husch Blackwell and Jaime Dwight at Promega.
-
Federal Acquisition Rules Get Measured Makeover
The Trump administration's promised overhaul of the Federal Acquisition Regulation is not a revolution in rules, but a meaningful recalibration of procurement practice that gives contracting officers more space to think, to tailor and to try, say attorneys at Mayer Brown.
-
Series
Mindfulness Meditation Makes Me A Better Lawyer
Mindful meditation enables me to drop the ego, and in helping me to keep sight of what’s important, permits me to learn from the other side and become a reliable counselor, says Roy Wyman at Bass Berry.
-
Lessons From 7th Circ. Decision Affirming $183M FCA Verdict
The Seventh Circuit's decision to uphold a $183 million False Claims Act award against Eli Lilly engages substantively with recurring materiality and scienter questions and provides insights into appellate review of complex trial court judgments, say Ellen London at London & Naor, Li Yu at Bernstein Litowitz and Kimberly Friday at Osborn Maledon.
-
AI Litigation Tools Can Enhance Case Assessment, Strategy
Civil litigators can use artificial intelligence tools to strengthen case assessment and aid in early strategy development, as long as they address the risks and ethical considerations that accompany these uses, say attorneys at Barnes & Thornburg.
-
Attys Beware: Generative AI Can Also Hallucinate Metadata
In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.
-
Calif. Justices Continued Anti-Arbitration Trend This Term
In the 2024-2025 term, the California Supreme Court justices continued to narrow arbitration's reach under state law, despite state courts' extreme caseload backlog and even as they embraced contractual autonomy in other contexts, says Josephine Petrick at The Norton Law Firm.
-
Steps For Healthcare Providers After Cigna ERISA Settlement
Following the Cigna class action's settlement, where Employee Retirement Income Security Act violations arose from Cigna's online provider directory advertising providers as in-network who were actually out-of-network, providers should routinely audit their contract status and directory listings, and proactively coordinate with plans and payor partners, say attorneys at ArentFox Schiff.
-
DOJ's UnitedHealth Settlement Highlights New Remedies Tack
The use of divestitures and Hart-Scott-Rodino Act compliance in the recent U.S. Department of Justice settlement with UnitedHealth Group and Amedisys underscores the DOJ Antitrust Division's willingness to utilize merger remedies under the second Trump administration, say attorneys at Buchanan Ingersoll.
-
When Atty Ethics Violations Give Rise To Causes Of Action
Though the Model Rules of Professional Conduct make clear that a violation of the rules does not automatically create a cause of action, attorneys should beware of a few scenarios in which they could face lawsuits for ethical lapses, says Brian Faughnan at Faughnan Law.
-
What's New In FDA's Latest Cell And Gene Therapy Guidance
New draft guidance from the U.S. Food and Drug Administration, along with other recent initiatives, come together to promote cell and gene therapy product development by streamlining development and review pathways, say attorneys at Holland & Knight.